First Randomized Trial of Treatment Strategies for Ewing Sarcoma Finds OS Differences

High-dose ifosfamide has been identified as a preferred therapy for relapsing-remitting Ewing sarcoma in a phase 3 ...

SEPTEMBER 6, 2022